Continuous, non-cell cycle-dependent expression of cyclin E is a characteristic feature of mouse embryonic stem cells (ESCs). We studied the 5′ regulatory region of Cyclin E, also known as Ccne1, and identified binding sites for transcription factors of the naïve pluripotency network, including Esrrb, Klf4, and Tfcp2l1 within 1 kilobase upstream of the transcription start site. Luciferase assay and chromatin immunoprecipitation-quantitative polymerase chain reaction (ChiP-qPCR) study highlighted one binding site for Esrrb that is essential to transcriptional activity of the promoter region, and three binding sites for Klf4 and Tfcp2l1. Knockdown of Esrrb, Klf4, and Tfcp2l1 reduced Cyclin E expression whereas overexpression of Esrrb and Klf4 increased it, indicating a strong correlation between the expression level of these factors and that of cyclin E. We observed that cyclin E overexpression delays differentiation induced by Esrrb depletion, suggesting that cyclin E is an important target of Esrrb for differentiation blockade. We observed that mESCs express a low level of miR-15a and that transfection of a miR-15a mimic decreases Cyclin E mRNA level. These results lead to the conclusion that the high expression level of Cyclin E in mESCs can be attributed to transcriptional activation by Esrrb as well as to the absence of its negative regulator, miR-15a.
Introduction
Cyclin E is a regulatory subunit of cyclin-dependent kinase (Cdk) 2 involved in many cellular processes including cell cycle progression, replication complex assembly, centrosome cycle, and epigenetic regulation. Its expression is regulated at both the transcriptional and protein level to achieve a timely control of cell division in connection with cell environment and fate decision. Deregulated expression of cyclin E has been shown to play a key role in tumorigenesis [1, 2] . Transcription of the Cyclin E gene, also known as Ccne1, is activated during the G1 phase and depends on mitogenic input, which is integrated through E2F and Myc transcription factors [3, 4] . E2F activity is regulated by phosphorylation of the retinoblastoma (Rb) protein in response to cyclin D/Cdk4 and cyclin D/Cdk6 kinase activity [5, 6] . The miRNA miR-15a was shown to act as a negative regulator of Cyclin E in somatic cells [7, 8] . Since, both Cyclin E and mir-15a are direct transcriptional targets of E2F, it raises the possibility that E2F, miR-15, and cyclin E constitute a feed-forward loop that modulates E2F activity and cell-cycle progression [8] .
There is a growing body of evidence showing that the cell cycle of mouse embryonic stem cells (ESCs) lacks some of the regulatory pathways that operate in somatic cells [9] [10] [11] .
These include extensive phosphorylation of the Rb family proteins despite little cyclin D/Cdk4 kinase activity [12] , p16 ink4a -resistant residual cyclin D3/Cdk6 kinase activity [13] , and lack of functional Chk/p53/p21 cip1 and Chk/Cdc25A pathways resulting in the absence of the DNA damage checkpoint in the G1 phase [14] [15] [16] . A key feature of the pluripotent stem cell cycle is the constitutive activity of Cdk2 due to seemingly continuous expression of both cyclin E and A throughout the cell cycle [17, 18] in addition to low expression levels of the Cdk2 inhibitors p21 cip1 , p27 kip1 , and p57 kip2 [12, 17] . In a previous report, we showed that cyclin E partially rescues ESC differentiation induced by leukemia inhibitory factor (LIF) starvation, suggesting that cyclin E participates in the regulation of pluripotency [19] . It was established that cyclin E:Cdk2 complexes phosphorylate and thereby stabilize the core pluripotency factors Nanog, Sox2, and Oct4 [20] . These findings point to a connection between the cell cycle machinery regulating G1/S phase transition and the core pluripotency network [21] .
In this context, it is important to understand how Cyclin E is transcriptionally regulated in pluripotent stem cells. We hypothesized that the transcription factors of the naïve pluripotency network would participate in the transcriptional regulation of Cyclin E. These factors include the cardinal pluripotency factors Oct4, Sox2, and Nanog, as well as the ancillary transcription factors Klf2, Klf4, Klf5, Esrrb, Tbx3, Gbx2, Nr0b1, and Tfcp2l1, all of which have been shown to sustain the naive state of pluripotency in mice [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . The present study points to Esrrb as a transcriptional activator and miR-15a as a negative regulator of Cyclin E in ESCs.
Material and Methods

In silico analysis
Published data were obtained from NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) and analyzed using UCSC Genome Browser ( [35] ;
http://genome.ucsc.edu). DNAse I hypersensitive sites, were identified from GSM1003830
(DNAseDgf on mESC-CJ7), GSM1014154 (DNAseHS on mESC-E14), and GSM1014187
(DNAseHS on mESC-CJ7) datasets. Histone marks were identified from GSM769008
(H3K4me3 on mESC-Bruce4), GSM1000089 (H3K27me3 on mESC-Bruce4) and GSM1000124 (H3K4me3 on mESC-E14) datasets. ChIP-seq data were from GSM288345 (Nanog), GSM288346 (Oct4), GSM288347 (Sox2), GSM288349 (E2f1), GSM288350
(Tfcp2I1), GSM288353 (Stat3), GSM288354 (Klf4), GSM288355 (Esrrb), and GSM288356
(c-Myc) compendiums [36] , and GSM470523 (Nr5a2) [37] and GSM1208217 (Klf4) [38] .
Several resources were used to predict the transcription factor binding site (TFBS)'s relative scores on the genomic sequence upstream of the Ccne1 gene, downloaded from the Ensembl database (genome assembly GRCm38/mm10, December 2011). 
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from cell pellets using TRIzol (Ambion) according to the manufacturer's protocol and reverse-transcribed using a High-Capacity RNA-to-cDNA kit (Applied Biosystems). For microRNAs reverse-transcription, a stem-loop primer specific to each miRNA was used. Real-time PCR was performed using the StepOnePlus real-time PCR system (Applied Biosystems) and Fast SBYR Green Master Mix (Applied Biosystems) according to the manufacturer's instructions. The relative quantitation of gene expression was calculated using StepOne Software 2.3 (Applied Biosystems). Expression of the target genes was normalized to those of the mouse b-actin gene (Actb) or to the mouse sno234 RNA for miRNA. Primers are listed in Table S1 .
ChIP-PCR
ChIP for Esrrb, Klf4, and Tfcp2l1 was performed on E14Tg2a ESCs using previously described protocols [46] . In brief, 10 7 cells were cross-linked with 1% formaldehyde for 15 min. Chromatin was sonicated to a length of less than 400 bp, and subsequently immunoprecipitated with 5 µg of anti-Esrrb (Perseus, pp-H6705-00), anti-Klf4 (Stemgent, 09-0021), and anti-Tfcp2l1 (AbCam, ab123354). DNA fragments encompassing binding sites for Esrrb, Klf4, and Tfcp2l1 in the P region of Cyclin E and the Nanog promoters were subsequently amplified by PCR. A 3′ untranslated region of the Cyclin E gene lacking putative binding sites for Esrrb, Klf4, and Tfcp2l1 was used as negative control. Primers are listed in Table S2 . ChIP-qPCR data obtained for each specific antibody were normalized using the percent input method that normalizes according to the amount of chromatin input. 
Plasmid constructs
Regions I (P) (1.5 kb), II (PE) (1.5 kb), and III (DE) (1.7 kb) of the Cyclin E gene 5′ flanking sequence were synthesized by GeneArt (Invitrogen) with appropriate restriction sites at both ends and subcloned into the pMA plasmid to generate pMA-P, pMA-PE, and pMA-DE plasmids, respectively (Table S3) Table S4) .
The shRNA sequences used to knock down Esrrb, Klf4, and Tfcp2l1 are described in with 10% fetal calf serum, 100 µM nonessential amino acids, 100 U/mL penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 bM 2-mercaptoethanol, and 1000 U/mL LIF. Routine culture of EKOiE ESCs included 1 µg/mL Doxycyclinz [49] .
Differentiation of E14Tg2a-Fucci cells was induced after withdrawal of LIF for 5 days.
Protocol for routine culture of EpiSCsis described elsewhere [50] . For colony assays, ESCs were plated at a density of 10 3 cells per gelatin-coated 100-mm tissue culture dish in complete ESC medium. Cells were exposed to the medium without doxycycline for 1 to 7 days. The protocol for in situ detection of alkaline phosphatase activity is described elsewhere [19] .
Infection with lentivirus vectors, flow cytometry, cell transfection and luciferase assay
Production of simian immunodeficiency virus (SIV)-derived lentivectors expressing the Fucci reporters mKO2:Cdt1, mAG:Geminin and infection of mouse ESCs are described elsewhere [19] . Cells were either analyzed using a LSRFortessa X-20 (Becton-Dickinson), or sorted with a FACSAria cell sorter (Becton-Dickinson) as described in [19] . 
Immunoblotting and immunolabeling
For immunoblotting, frozen cell pellets were lysed in RIPA buffer complemented with protease and phosphatase inhibitors. Protein lysates were then cleared by centrifugation 
Results
Cell cycle expression patterns of cyclins and pluripotency factors
Expression patterns of Cyclin E (Ccne1), Cyclin E2 (Ccne2), and Cyclin A (Ccna1) were examined during differentiation of ESCs into embryoid bodies, and compared with that of transcription factors implicated in the regulation of pluripotency including Oct4, Sox2, Nanog, Esrrb, Klf2, Klf4, Klf5, and Tfcp2l1. Only Cyclin E mRNA decreased during differentiation concomitantly with mRNA of all the transcription factors analyzed (Fig. 1A) . We next examined the expression of pattern for Cyclin E, Cyclin E2, and Cyclin A, and for 10 pluripotency genes (Oct4, Sox2, Nanog, Esrrb, Klf2, Klf4, Gbx2, Tfcp2l1, Stat3 and Nr5a2) in each phase of the cell cycle in ESCs using the Fucci reporter to sort cells out according to their position in the cell cycle (Fig. 1B) . No significant variation in mRNA levels for Cyclin E and for the 10 pluripotency genes was observed between mAG(-)/mKO2(-) (G1 phase), mAG(+)/mKO2(-) (S phase), and mAG(++)/mKO2(-) (G2 phase) (Fig. 1C) . In line with expression patterns described in somatic cells, Cyclin E2 and Cyclin A showed lower and higher expression in the G2 phase, respectively. Note that the mAG(-)/mKO2(+) fraction (cells in the late G1 phase) were excluded from analysis as most of them displayed low or no expression of Oct4 (Suppl. phase with respect to the G2 phase (Fig. 1D) . Examination of transcripts levels in a whole cell population of EpiSC revealed both a strong reduction for all naïve pluripotency markers and a 70% reduction for Cyclin E ( Figure 1E ). Taken 
Mapping of cis-regulatory elements in the 5′ flanking region of Cyclin E
We examined the transcriptional regulation of Cyclin E by transcription factors of the naïve pluripotency network. The distribution of DNAse I hypersensitivity sites was analyzed over a 15 kb region encompassing the Cyclin E transcription start site in two mouse ESC lines, CJ7
and E14Tg2a, using data available in the mouse ENCODE data base. We identified three regions hypersensitive to DNAse I in the 5′ flanking region: region I between the transcription start site and −1.2 kb, region II between −4.5 and −6 kb, and region III between −9.8 and −11.5 kb ( Fig. 2A) . In both Bruce4 and E14Tg2a ESCs, region I and II displayed a strong and moderate enrichment in H3K4me3 histone marks, respectively. The transcription-promoting activity of the three regions was analyzed using a luciferase assay after transfection into E14Tg2a ESCs (Fig. 2B) . Region I showed high transcriptional activity, region II enhanced this activity by a factor of two, and region III reduced it by a factor of two. Regions I, II, and III were thereafter called "promoter" (P), "Proximal Enhancer" (PE), and "Distal regulator Element" (DE), respectively. After transfection into a mouse fibroblast (STO) cell line, luciferase activity was dramatically reduced compared with that observed in ESCs, in line with the reduced transcript levels observed after ESC differentiation. Moreover, in contrast to the situation observed in ESCs, the PE region had no enhancer activity on transcription initiated from the P region.
Using the JASPAR database [39] , putative binding sites for the pluripotency regulators Oct4, Sox2, Esrrb, Tfcp2l1, Klf4, Klf5, Tcf3, and STAT3 were identified in the P and PE regions (Suppl. Fig. 2 ). Binding sites for E2F1 and Nr5a2 were also identified in the P region as previously reported [3, 4, 51] . Binding of transcription factors to their respective sites was analyzed from published ChIP-seq data [36, 38] . We identified a strong enrichment in P region-specific sequences after chromatin immunoprecipitation with Esrrb, Tfcp2l1, Klf4, and E2F antibodies, but not with Oct4, Sox2, Nanog, Stat3, Nr5a2 and cMyc antibodies (Fig. 2C) . Based on these results, all subsequent analyses focused on the role of Esrrb, Tfcp2l1, and Klf4 in the transcriptional regulation of Cyclin E via the P region. None of these mutations significantly altered the transcriptional activity of the P region when transfected into STO fibroblast cells. We concluded that the distal Esrrb binding site was essential to the transcriptional activity of the promoter element of Cyclin E in ESCs, and the proximal Esrrb site and the Tfcp2l1 site play ancillary roles. Luciferase activity associated with pGL4.10-P was also strongly reduced in EpiSC as compared to ES cells (Figure 3c) , suggesting that the Cyclin E promoter region is less active in the primed state than in the naïve state of pluripotency.
Esrrb
Binding of Esrrb, Tfcp2l1, and Klf4 to the P region of Cyclin E was measured using previously published ChIP-seq data [36] . We observed a high occupancy of Esrrb binding sites at positions −538/−548 and −870/−880 ( Figure 3D ; Suppl. 
Regulation of Cyclin E by Esrrb, Tfcp2l1, and Klf4
To further substantiate the implication of Esrrb, Tfcp2l1 and Klf4 in the transcriptional regulation of Cyclin E, their expression was knocked down by means of doxycyclin-induced expression of two independent shRNAs (Sh#1 and Sh#2) in KH2 ESCs [48] . The expression levels of Esrrb, Klf4, and Tfcp2l1 could be reduced to less than 10% after 48 h induction with doxycycline for sh#1 ( Figure 4A) . Cyclin E transcript levels showed a correlated decrease compared to control cells after knockdown of Esrrb (77%), Tfcp2l1 (69%) and Klf4 (74%), respectively. In ESCs expressing Sh#2, doxycycline treatment resulted in a substantially smaller reduction of Esrrb, Tfcp2l1, and Klf4 transcript levels than Sh#1 (i.e. to 25%, 63%, and 30% of their original levels, respectively). Nevertheless, the Cyclin E transcript level was significantly reduced (65%, 61%, and 24%, respectively). Esrrb and Tfcp2l1 knockdown is not a consequence of differentiation (Suppl . Fig. 4 ). In contrast, Klf4 knockdown resulted in a significant attenuation of most of the aforementioned pluripotency regulators. As the Klf4 binding sites are apparently not involved in the transcriptional regulation of Cyclin E, the observed downregulation of Cyclin E in shKlf4
ESCs might be explained by a substantial rate of spontaneous differentiation. In the next step, Esrrb, Klf4, and Tfcp2l1 were overexpressed using a doxycycline-inducible vector system in KH2 ESCs (Figure 4C ). This resulted in a 2.7-and 2.2-fold increase in Cyclin E transcript levels after Esrrb and Klf4 overexpression, respectively. No significant increase was observed after Tfcp2l1 overexpression. These results were confirmed by the analysis of Cyclin E, Esrrb, Tfcp2l1, and Klf4 protein levels ( Figure 4D) . For Tfcp2l1 overexpression, Cyclin E increase was observed only at the protein level, which may suggest a post-transcriptional regulation. Together, these results indicate a strong correlation between the expression levels of Esrrb and Cyclin E.
Partial rescue of Esrrb knockdown-induced differentiation by Cyclin E
Several studies have pointed to Esrrb as an inducer of somatic cell reprogramming and ESC self-renewal [29, 30, 54] . The role of Esrrb in the regulation of Cyclin E therefore prompted us to investigate the capacity of cyclin E to oppose Esrrb knockdown-induced differentiation.
We therefore used EKOiE cells expressing doxycycline-regulated Esrrb cDNA in an Esrrbnull background [49] . After doxycycline deprivation for 48 h, Esrrb was undetectable.
Consequently, a twofold reduction of both Cyclin E mRNA and cyclin E protein was observed ( Figure 5A) . Expression of Tfcp2l1 and Klf4 were also reduced, which may have contributed to the downregulation of Cyclin E ( Figure 5B) . When doxycycline-deprived EKOiE cells were supplemented with doxycycline for 48 h, they restored expression of Esrrb, Tfcp2l1, Klf4, and Cyclin E to their original levels. Expression of Oct4 and Sox2 remained unchanged in this experimental setting. Next, EKOiE cells were transfected with a plasmid carrying a Myc-tagged rat cyclin E cDNA, or with an empty plasmid [55] ( Figure 5C ).
EKOiE-
Myc cyclin E and EKOiE-control cell populations were analyzed using a colonyforming assay to assess the balance between self-renewal and differentiation ( Figure 5D ).
Withdrawal of doxycycline resulted in a gradual increase of the proportion of mixed and differentiated colonies indicating that the loss of Esrrb disrupted self-renewal as previously reported [30] . In the presence of doxycyline, no difference was observed between EKOiE-
Myc cyclin E and control cells regarding the proportion of undifferentiated, mixed, and differentiated colonies, suggesting that enforced expression of cyclin E has no observable effect on self-renewal in the presence of Esrrb. In contrast, the withdrawal of doxycycline for 3, 5, and 7 days, leads to a significantly increased proportion of mixed and undifferentiated colonies in EKOiEMyc cyclin E cells when compared to control cells. These results strongly suggest that enforced expression of cyclin E opposes ESC differentiation induced by downregulation of Esrrb.
Regulation of Cyclin E transcript level by miR-15a
MicroRNA miR-15a was shown to act as a negative regulator of Cyclin E in somatic cells [7, 8] . We therefore asked if the decrease in Cyclin E transcript levels observed during ES cell differentiation could also be a result of a rise in miR-15a levels. A qRT-PCR analysis revealed that changes in miR-15a expression mirrored those of Cyclin E between 1 and 9 days of differentiation, suggesting a cross-regulation (Fig. 6A) . To demonstrate the regulation of Cyclin E expression levels by miR-15a, E14Tg2a ESCs were transfected with a miR-15a-5p mimic, resulting in a 58% reduction of Cyclin E transcripts levels after 48 hours of culture.
Nanog transcript levels were also decreased, albeit to a lesser extend (41%) (Fig. 6B) . These results strongly suggest that the reduced levels of Cyclin E upon differentiation might at least partially be attributed to an increased expression of miR-15a.
Discussion
In somatic cells, expression of cyclin E varies during the cell cycle, reaching a maximum at the G1/S phase boundary. Repression of the cyclin E gene during G2/M and the early G1 phase of the cell cycle are mediated through the assembly of a multiprotein complex containing hypophosphorylated Rb, a histone deacetylase as well as the SWI/SNF chromatin remodeling complex, which bind to the cyclin E promoter in order to silence transcription. Transcriptional activation of the cyclin E gene during progression through the G1 phase depends on the activity of cyclin D/Cdk4 and cyclin D/Cdk6 complexes, which phosphorylate and inactivate retinoblastoma protein (pRb) leading to the release of the repressor proteins of the E2F-transcription factor family [56] . In mouse ESCs, cell cycle regulation of Cyclin E seems to obey a different rule. Despite very low levels of D-type cyclins [12, 17] [57], the G1-specific hypophosphorylated form of Rb is almost absent [17, 58] , and essentially all E2F transcription factors are free from Rb proteins and bind the cyclin E promoter to stimulate transcription, regardless of the cell's growth cycle position [18] . The theory of a continuous and uniform expression of Cyclin E was challenged in a recent study using ESCs synchronized with nocodazole, showing that Cyclin E transcripts indeed reached a maximum during G1 phase [59] . Strikingly, a similar cell cycle-dependent pattern was observed for Nanog and Esrrb. In sharp contrast, we did not observe a similar pattern using nonsynchronized ESC-Fucci, which raises the question of whether chemically-synchronized ESC can regulate gene expression after release from the mitotic block.
Esrrb, Tfcp2l1, and Klf4 are three transcription factors implicated in the control of naive pluripotency. Esrrb is a direct target gene of both Nanog and the GSK3/b-catenin/Tcf3 pathway [29, 30] , and both Tfcp2l1 and Klf4 are direct target genes of the LIF/STAT3 signaling pathway [23, 25, 33] . In the present study, we showed that Cyclin E is a direct target of these three transcription factors, pointing to regulation of cyclin E expression by the gene regulatory circuitry that controls naive pluripotency. Among the three factors studied, Esrrb seems to play a major role as shown, first, by the dramatic reduction of transcriptional activity from the promoter region lacking the distal Esrrb binding site, and second, by the downregulation of Cyclin E after Esrrb expression has been knocked down or turned off. a transcription factor involved in the control of naive pluripotency [60] . In addition, Nr5a2
has been shown to regulate expression of Cyclin E in conjunction with β-catenin in intestinal crypt cells [51] . In ESCs, mutation of the Esrrb/Nr5a2 binding site has only a minor effect on the transcriptional activity of the promoter region and ChIP-seq studies revealed no binding of Nr5a2 to the promoter region of Cyclin E, strongly suggesting that Nr5a2 plays no role in
Cyclin E transcriptional regulation in ESCs.
We showed that microRNA miR-15a is a negative regulator of Cyclin E in ESCs, in line with its function in somatic cells [7, 8] . Thus, we propose a regulatory model of Cyclin E expression, in which the elevated level of Cyclin E transcripts observed in ESCs results from both a transcriptional activation by Esrrb and a lack of negative regulation by miR-15a.
Differentiation would trigger both the down-regulation of Esrrb and the elevation of miR-15a, resulting in a rapid drop in Cyclin E transcript level. Interestingly, miR-15a is a key direct transcriptional target of E2F in somatic cells [8] . Low expression of miR-15a in ESCs and its up-regulation during differentiation strongly suggests that E2F activity is very low in ESCs, and it is only restored after exit from naïve pluripotency.
We showed that mouse EpiSCs, which epitomize the primed state of pluripotency,
express Cyclin E at a much lower level as compared to the naïve ESCs. We know little about cell cycle regulation in mouse EpiSCs. However, human ESCs, i.e. the human counterparts of mouse EpiSCs, seem to exhibit a somatic-like cell-cycle regulation. In particular, it was observed that Cyclin E mRNA levels increases sharply at the G1/S transition and that the 
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